What is rapid Evidence Mapping (rEM)?

Evidence Mapping facilitates evidence-based decision making, highlights knowledge gaps, and identifies future research needs.

A rapid Evidence Map (rEM) is a resource-efficient knowledge synthesis in which the systematic review process is accelerated via use of machine learning. The rEM utilizes a systematic literature search and provides a visual representation of scientific evidence in a timely manner. It utilizes rigorous, transparent and explicit methodological approaches and can be applied to a wide range of topics in clinical, environmental health, and related scientific disciplines.

Our rEM approach enables: (1) identification of areas where the most research has been conducted; (2) identification of potential evidence gaps where more research is needed; and (3) data-driven decision making for future research efforts or to target areas where sufficient information may exist for pursuing a systematic review.

Our Rapid Evidence Mapping approach combines machine learning tools with expertise of a review team to rapidly synthesize evidence maps. Our published benchmarking shows rEM can save ~90% of time while producing results similar to a traditional EM.

A Rapid Evidence Map typically includes:

Our Unique Approach for rapid Evidence Mapping

We work with our clients at all stages of the rEM process – problem formulation, protocol development, literature screening, and data analyses using off-the-shelf and custom designed methodologies, interpretation of results and manuscript preparation. Our consulting team includes PhD-level Systematic Review, Information Specialist, Public Health, and Data Science professionals with experience in government contracting, academic research, and industry.

Project Development

Title and Abstract Screening

Literature Search Strategy

Create Evidence Map and Final Report

Sciome’s rapid Evidence Map of COVID-19 Risk and Protective Factors Published in Frontiers in Public Health

COVID-19 is a novel virus that has contributed to a worldwide pandemic unlike any other that most of us have seen in this lifetime. The rapid spread of the disease has shuttered the world’s economy and productivity, but in turn has also sparked a great deal of interest in the scientific community and is the topic of a rapidly growing body of literature. Sciome has recently completed a rapid Evidence Map (rEM) of risk and protective factors in the COVID-19 literature published in early 2020, utilizing a structured framework to summarize this compilation of scientific information, in particular highlighting where there is a wealth of evidence and also where gaps in the literature exist. To our knowledge, this is the first evidence map that explores the available scientific literature related to risk and protective factors for COVID-19.

We have identified promising research areas (e.g., age, gender and comorbidity association with COVID-19) where there exists sufficient literature to potentially inform a follow-up review, such as a systematic review, and other areas (e.g., risk factors in susceptible sub-groups, risk factors in children, protective factors in general) where evidence is lacking where further research may be necessary. The resulting rEM, which was completed within one calendar month, represents a useful tool for quickly synthesizing the COVID-19 literature and identifying resource-rich/resource-poor areas that may benefit from future research as the pandemic evolves over time.

Our COVID-19 rEM is available here: Risk and Protective Factors in the COVID-19 Pandemic: A Rapid Evidence Map